Effect of new direct-acting antiviral drugs on insulin resistance and glycemic control after treatment of chronic hepatitis C virus infection in type 2 diabetic patients

Effect of new direct-acting antiviral drugs on insulin resistance and glycemic control after treatment of chronic hepatitis C virus infection in type 2 diabetic patients

Background Hepatitis C virus (HCV) infection is associated with diabetes and may worsen glycemic control in patients with diabetes. The benefits of eradicating HCV infection with direct-acting antiviral (DAAs) may go well beyond avoiding the damage caused by chronic liver inflammation, to include de...

Full description

Bibliographic Details
Main Authors:	Alaa E.M Hashim, Hanaa T Kandeel, Olfat M Hendy, Khaled El-Mola, Fathyia M El-Raey, Mohamed S.M Attia
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Al-Azhar Assiut Medical Journal
Subjects:	antidiabetic drugs; antiviral drugs diabetes glycated hemoglobin hepatitis c virus insulin resistance insulin oral hypoglycemic
Online Access:	http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2017;volume=15;issue=4;spage=187;epage=195;aulast=Hashim

Similar Items

Conventional antidiabetic agents and bone health: A pilot case–control study
by: Jeffrey Pradeep Raj, et al.
Published: (2019-01-01)

Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes
by: Rumiko Shimazawa, et al.
Published: (2019-11-01)

Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
by: Mohamed Mohei El Badry, et al.
Published: (2020-11-01)

Neck circumference in relation to glycemic parameters: a systematic review and meta-analysis of observational studies
by: Parvane Saneei, et al.
Published: (2019-06-01)

Modern approaches to the treatment of type 2 diabetes mellitus
by: T. V. Morgunova, et al.
Published: (2018-03-01)

The treatment of diabetes mellitus of patients with chronic liver disease
by: Diego García-Compeán, et al.
Published: (2015-11-01)

How many oral antidiabetic drugs before insulin?
by: Jayant Kelwade, et al.
Published: (2017-01-01)

Glycemic control in patients with diabetes mellitus on hemodialysis
by: K G Lobanova, et al.
Published: (2019-10-01)

A stewardship intervention program for safe medication management and use of antidiabetic drugs
by: Zhao RY, et al.
Published: (2015-07-01)

Consumption of antidiabetic medicines in Portugal: results of a temporal data analysis of a thirteen‐year study (2005–2017)
by: Artur Mendes Moura, et al.
Published: (2021-02-01)

Hypoglycemic Effect of Resveratrol: A Systematic Review and Meta-Analysis
by: Beatriz Isabel García-Martínez, et al.
Published: (2021-01-01)

Assessment of the serum level of melatonin and its correlation with insulin, insulin resistance, and glycated hemoglobin in Iraqi patients with polycystic ovarian syndrome
by: Ahmed Abduljabbar Hameed, et al.
Published: (2019-01-01)

Analysis of the regional pharmaceutical market of hypoglycemic drugs of oral administration
by: Orlova T.S., et al.
Published: (2017-06-01)

Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus in a Semi-Urban Brazilian Population
by: Nayla Cristina do Vale Moreira, et al.
Published: (2019-09-01)

Insulin poisoning with suicidal intent
by: Abhay Gundgurthi, et al.
Published: (2012-01-01)

Phospholipid complex based nanoemulsion system for oral insulin delivery: preparation, in vitro, and in vivo evaluations
by: Hu XB, et al.
Published: (2019-05-01)

Antidiabetic activity enhancement in streptozotocin + nicotinamide–induced diabetic rats through combinational polymeric nanoformulation
by: Rani R, et al.
Published: (2019-06-01)

Evaluation of the achievement of target glycemic levels in children and adolescents with type 1 diabetes mellitus with insulin pump therapy according to a modified training program
by: A.B. Tashmanova, et al.
Published: (2021-06-01)

Nanoparticle Delivery Systems in the Treatment of Diabetes Complications
by: Eliana B. Souto, et al.
Published: (2019-11-01)

Practical combination therapy based on pathophysiology of type 2 diabetes
by: Levin PA
Published: (2016-10-01)

Anti-diabetic functional foods as sources of insulin secreting, insulin sensitizing and insulin mimetic agents
by: Mutiu Idowu Kazeem, et al.
Published: (2016-01-01)

Facts about type 2 diabetes mellitus and its control in Misan Governorate. Single-center experience
by: Yaseen Yaseen, et al.
Published: (2018-12-01)

Association of serum free thyroxine and glucose homeostasis: Korea National Health and Nutrition Examination Survey
by: Jeonghoon Ha, et al.
Published: (2021-03-01)

Efficacy and pathogenetic justification for the use of vildagliptin in patients with type 2 diabetes mellitus
by: V.I. Pankiv
Published: (2019-10-01)

The Effect of the Paleolithic Diet vs. Healthy Diets on Glucose and Insulin Homeostasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Małgorzata Jamka, et al.
Published: (2020-01-01)

The incidence of hypoglycemia among insulin-treated patients with Type 1 or Type 2 diabetes: Bangladeshi cohort of international operations-hypoglycemia assessment tool study
by: Md. Faruque Pathan, et al.
Published: (2018-01-01)

Challenge of diabetes mellitus and researchers’ contributions to its control
by: Odularu Ayodele T., et al.
Published: (2021-05-01)

Renal Outcomes Associated with the Use of Non-Insulin Antidiabetic Pharmacotherapy: A Review of Current Evidence and Recommendations
by: Elnaem MH, et al.
Published: (2020-12-01)

Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study
by: Jun Sung Moon, et al.
Published: (2021-09-01)

Underutilization of insulin and better metabolic control. A NOVA clinic experience
by: Héctor Eloy Tamez-Pérez, et al.

Glucose Metabolism Evaluated by Glycated Hemoglobin and Insulin Sensitivity Indices in Children Treated with Recombinant Human Growth Hormone
by: Maria Chiara Pellegrin, et al.
Published: (2019-12-01)

Fasts, feasts and festivals in diabetes-1: Glycemic management during Hindu fasts
by: Sanjay Kalra, et al.
Published: (2015-01-01)

Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
by: Elena Efimovna Petryaykina, et al.
Published: (2009-09-01)

Self-adjusting doses of oral antihyperglycemic therapy using repaglinide or glyburide in type 2 diabetes : the soaring study
by: MacKinnon, Lindsay M.
Published: (2006)

Insulin Toujeo® — a Novel Basal Long-Acting Insulin Formulation. Part 2. Clinical Efficacy and Safety
by: V.V. Poltorak, et al.
Published: (2015-11-01)

Clinical Experience with Biphasic Insulin Aspart 30 Treatment in Patients with Type 2 Diabetes Poorly Controlled on Oral Antidiabetic Drugs: The Turkish PRESENT Study
by: Serdar Güler, et al.
Published: (2008-05-01)

A medley correlation of serum zinc with glycemic parameters in T2DM patients
by: Santosh K Naik, et al.
Published: (2019-01-01)

ANTIDIABETIC ACTIVITY OF GUANIDINIUM SALT 2-AMINOPHENYLACETATE
by: E. V. Ponomarenko
Published: (2019-01-01)

Antidiabetic effect of Psychotria malayana Jack in induced type 1 diabetic rat
by: Fairuz Fairuz, et al.
Published: (2020-04-01)

Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring within a Real-World Setting: The GoBolus Study
by: Axel Schweitzer, M., et al.
Published: (2021)